Health Condition 1: A00-B99- Certain infectious and parasitic diseases
Conditions
Interventions
Intervention1: Curaneum 20: In the intervention arm one drop of Curaneum 20 will be provided in patientsâ?? mouth twice daily for five days.
Control Intervention1: Placebo: In the Comparator group of
Sponsors
Dr Sant Prabhudasji
Eligibility
Inclusion criteria
Inclusion criteria: · Age >18 years · Laboratory confirmed infection with SARS-Cov-2 · In patient admission to SARS-Cov-2 therapy · Signed informed consent
Exclusion criteria
Exclusion criteria: · Patients · Pregnant or breast-feeding · Participating in other clinical trial · Not signing informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Discharge after cure or deathTimepoint: till the patient is discharged or died | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Proportion of patients treated with Curaneum 20 who remain treated without inten-sive care compared to control 2. Comparing Curaneum 20 treated patients with placebo control for the period till the patient becomes Covid test negative 3. The evaluation of Curaneum 20 for any drug related adverse event Timepoint: at the time of discharge or death | — |
Countries
India
Contacts
Public ContactArunaloke Chakrabarti
Department of Medical Microbiology, PGIMER, Chandigarh
Outcome results
None listed